Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardioprotection mediated by urocortin is dependent on PKCepsilon activation.
Lawrence KM, Kabir AM, Bellahcene M, Davidson S, Cao XB, McCormick J, Mesquita RA, Carroll CJ, Chanalaris A, Townsend PA, Hubank M, Stephanou A, Knight RA, Marber MS, Latchman DS. Lawrence KM, et al. Among authors: kabir am. FASEB J. 2005 May;19(7):831-3. doi: 10.1096/fj.04-2506fje. Epub 2005 Mar 10. FASEB J. 2005. PMID: 15764590
Activation of p38 mitogen-activated protein kinase contributes to the early cardiodepressant action of tumor necrosis factor.
Bellahcene M, Jacquet S, Cao XB, Tanno M, Haworth RS, Layland J, Kabir AM, Gaestel M, Davis RJ, Flavell RA, Shah AM, Avkiran M, Marber MS. Bellahcene M, et al. Among authors: kabir am. J Am Coll Cardiol. 2006 Aug 1;48(3):545-55. doi: 10.1016/j.jacc.2006.02.072. Epub 2006 Jul 12. J Am Coll Cardiol. 2006. PMID: 16875982 Free article.
MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia.
Gorog DA, Jabr RI, Tanno M, Sarafraz N, Clark JE, Fisher SG, Cao XB, Bellahcene M, Dighe K, Kabir AM, Quinlan RA, Kato K, Gaestel M, Marber MS, Heads RJ. Gorog DA, et al. Among authors: kabir am. Cell Stress Chaperones. 2009 Sep;14(5):477-89. doi: 10.1007/s12192-009-0101-5. Epub 2009 Feb 13. Cell Stress Chaperones. 2009. PMID: 19214782 Free PMC article.
Electrical remodeling following percutaneous pulmonary valve implantation.
Plymen CM, Bolger AP, Lurz P, Nordmeyer J, Lee TY, Kabir A, Coats L, Cullen S, Walker F, Deanfield JE, Taylor AM, Bonhoeffer P, Lambiase PD. Plymen CM, et al. Among authors: kabir a. Am J Cardiol. 2011 Jan 15;107(2):309-14. doi: 10.1016/j.amjcard.2010.09.017. Am J Cardiol. 2011. PMID: 21211609
Coronary artery height differences and their effect on fractional flow reserve.
Al-Janabi F, Karamasis G, Cook CM, Kabir AM, Jagathesan RO, Robinson NM, Sayer JW, Aggarwal RK, Clesham GJ, Kelly PR, Gamma RA, Tang KH, Keeble TR, Davies JR. Al-Janabi F, et al. Among authors: kabir am. Cardiol J. 2021;28(1):41-48. doi: 10.5603/CJ.a2019.0031. Epub 2019 Mar 26. Cardiol J. 2021. PMID: 30912578 Free PMC article. Clinical Trial.
Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.
Bulluck H, Fröhlich GM, Mohdnazri S, Gamma RA, Davies JR, Clesham GJ, Sayer JW, Aggarwal RK, Tang KH, Kelly PA, Jagathesan R, Kabir A, Robinson NM, Sirker A, Mathur A, Blackman DJ, Ariti C, Krishnamurthy A, White SK, Meier P, Moon JC, Greenwood JP, Hausenloy DJ. Bulluck H, et al. Clin Cardiol. 2015 May;38(5):259-66. doi: 10.1002/clc.22401. Clin Cardiol. 2015. PMID: 25990305 Free PMC article. Clinical Trial.
84 results